(Q61863467)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557240%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Redirection of CMV-specific CTL towards B-CLL via CD20-targeted HLA/CMV complexes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557240%20AND%20SRC:MED&resulttype=core&format=json

B-cell chronic lymphocytic leukemia

18 January 2020

main subject

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557240%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Ester B. Remmerswaal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557240%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Rene van Lier

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557240%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Mous R

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557240%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Eldering E

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557240%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

van Oers MH

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557240%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

1 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557240%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557240%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557240%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557240%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

1096-1102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557240%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404185

18 January 2020

exact match

0 references

cites work

Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404185

7 January 2021

Analysis of the expression of critical activation/interaction markers on peripheral blood T cells in B-cell chronic lymphocytic leukaemia: evidence of immune dysregulation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404185

7 January 2021

Eradication of B-CLL by autologous and allogeneic host nonreactive anti-third-party CTLs.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404185

7 January 2021

Generation of B-cell chronic lymphocytic leukemia (B-CLL)-reactive T-cell lines and clones from HLA class I-matched donors using modified B-CLL cells as stimulators: implications for adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404185

7 January 2021

Apoptotic tumor cells are superior to tumor cell lysate, and tumor cell RNA in induction of autologous T cell response in B-CLL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404185

7 January 2021

Expansion of CMV-specific CD8+CD45RA+CD27- T cells in B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404185

7 January 2021

Differentiation of cytomegalovirus-specific CD8(+) T cells in healthy and immunosuppressed virus carriers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404185

7 January 2021

Human CD8(+) T cell responses against five newly identified respiratory syncytial virus-derived epitopes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404185

7 January 2021

Autologous cytomegalovirus-specific T cells as effector cells in immunotherapy of B cell chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404185

7 January 2021

Guidelines on the diagnosis and management of chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404185

7 January 2021

Aberrant expression and reverse signalling of CD70 on malignant B cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404185

7 January 2021

Proliferation requirements of cytomegalovirus-specific, effector-type human CD8+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404185

7 January 2021

Induction of viral and tumour specific CTL responses using antibody targeted HLA class I peptide complexes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404185

7 January 2021

Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404185

7 January 2021

Direct ex vivo analysis of human CD4(+) memory T cell activation requirements at the single clonotype level

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404185

7 January 2021

Anti-viral cytotoxic T cells inhibit the growth of cancer cells with antibody targeted HLA class I/peptide complexes in SCID mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404185

7 January 2021

Tumor-specific Ab-mediated targeting of MHC-peptide complexes induces regression of human tumor xenografts in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404185

7 January 2021

Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404185

7 January 2021

Antibody-targeted MHC complex-directed expansion of HIV-1- and KSHV-specific CD8+ lymphocytes: a new approach to therapeutic vaccination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404185

7 January 2021

Interferon-γ: an overview of signals, mechanisms and functions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404185

7 January 2021

Tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404185

7 January 2021

Macrophage inflammatory protein-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404185

7 January 2021

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404185

7 January 2021

CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404185

7 January 2021

Safety of yttrium-90 ibritumomab tiuxetan radioimmunotherapy for relapsed low-grade, follicular, or transformed non-hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404185

7 January 2021